Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)
Clinical trial NCT06032845 · RECRUITING
Trial details
- NCT number
- NCT06032845
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-13
- Primary completion
- 2025-12-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.